120
Participants
Start Date
September 30, 2019
Primary Completion Date
September 30, 2024
Study Completion Date
September 30, 2024
Ropivacaine Infusion from ON-Q Pump
Infusion of 0.2% ropivacaine at 8 mL/hour for 72 hours
Ropivacaine + Ketorolac Infusion from ON-Q Pump
Infusion of 0.2% ropivacaine + 30 mg ketorolac at 8 mL/hour for 72 hours
Normal Saline Infusion from ON-Q Pump
Infusion of 0.9% normal saline at 8 mL/hour for 72 hours
RECRUITING
MedStar Washington Hospital Center, Washington D.C.
RECRUITING
The GW Medical Faculty Associates, Washington D.C.
Collaborators (1)
Avanos Medical
OTHER
Ying Liu
OTHER